Table 6.
Independent Factors | PFS | OS | ||
---|---|---|---|---|
Hazard Ratio (95% Confidence Interval) |
p | Hazard Ratio (95% Confidence Interval) |
p | |
Performance status | ||||
PS 0 | 1 (reference) | 1 (reference) | ||
PS 1 | 1.2 (0.7–2.3) | 0.534 | 1.8 (0.9–3.5) | 0.094 |
Gender | ||||
Male | 3.2 (1.5–6.6) | 0.002 | 2.6 (1.3–5.2) | 0.007 |
Female | 1 (reference) | 1 (reference) | ||
Line of osimertinib | ||||
Second line | 1.0 (0.5–1.7) | 0.835 | 1.1 (0.6–2.2) | 0.751 |
>Second line | 1 (reference) | 1 (reference) | ||
T790M (plasma and/or tissue) | ||||
Detected | 1.0 (0.5–2.0) | 0.886 | 1.0 (0.5–2.0) | 0.955 |
Not detected | 1 (reference) | 1 (reference) | ||
Baseline ctDNA | ||||
Detected | 2.3 (1.2–4.5) | 0.015 | 2.9 (1.3–6.2) | 0.007 |
Not detected | 1 (reference) | 1 (reference) |
p-values marked with bold indicate statistically significant.